EN523

CAS No. 2094893-05-5

EN523 ( —— )

Catalog No. M28951 CAS No. 2094893-05-5

EN523 targets non-catalytic allosteric cysteine C23 in K48 ubiquitin-specific deuquitinase OTUB1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 147 Get Quote
10MG 260 Get Quote
25MG 520 Get Quote
50MG 750 Get Quote
100MG 1035 Get Quote
500MG 2061 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EN523
  • Note
    Research use only, not for human use.
  • Brief Description
    EN523 targets non-catalytic allosteric cysteine C23 in K48 ubiquitin-specific deuquitinase OTUB1.
  • Description
    EN523 targets non-catalytic allosteric cysteine C23 in K48 ubiquitin-specific deuquitinase OTUB1.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Nav1.7 channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2094893-05-5
  • Formula Weight
    234.3
  • Molecular Formula
    C12H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=CC=C(O1)N1CCN(CC1=O)C(=O)C=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kornecook TJ, et al. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel NaV1.7. J Pharmacol Exp Ther. 2017 Jul;362(1):146-160.
molnova catalog
related products
  • Slingshot inhibitor ...

    Slingshot inhibitor D3 is a potent inhibitor of the Protein Phosphatase Slingshot.

  • Glyoxylic acid monoh...

    Glyoxylic acid or oxoacetic acid is an organic compound that is both an aldehyde and a carboxylic acid.It is an intermediate of the glyoxylate cycle which enables certain organisms to convert fatty acids into carbohydrates. The conjugate base of glyoxylic acid is known as glyoxylate.

  • ZINC77292789

    Fmoc-Thr[GalNAc(Ac)3-α-D]-OH is a reagent for the preparation of a synthetic MUC1 Glycopeptide Bearing βGalNAc-?Thr as a Tn antigen isomer which induces the antibody production against tumor cells. Fmoc-Thr[GalNAc(Ac)3-α-D]-OH is a starting material to make trimeric MUC1 immunodominant motif antigen-?based anti-?cancer vaccine candidates.